3
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Effect of TPA, Okadaic Acid and 1α,25-dihydroxyvitamin D3 on Neoplastic Transformation Induced by 60Co Gamma-rays or 252Cf Fission Neutrons in Balb/c 3T3 Cells

, &
Pages 253-262 | Received 20 Dec 1990, Accepted 21 Jul 1991, Published online: 03 Jul 2009
 

Abstract

The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA), 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] and okadaic acid were individually examined on the neoplastic transformation of Balb/c 3T3 cells which were exposed to either 60Co gamma-rays or 252Cf fission neutrons. The addition of 1α,25(OH)2D3, or TPA, enhanced the transformation induced by gamma-rays or low doses of fission neutrons. No enhancement was observed by the addition of okadaic acid except at toxic concentrations (5 ng/ml) and with higher doses of radiation. Moreover, the enhancement of transformation by either 1α,25(OH)2D3 or TPA decreased as the radiation dose was increased. The enhancement ratio, calculated by least-square analysis from 0 Gy to 1 Gy, was greater for 1α,25(OH)2D3 than for TPA, and also greater for gamma-ray irradiation than for neutron irradiation. These results suggest that the promotion of radiation-induced transformation depends on the level of the initial damage caused by radiation, and that the differences in the enhancement properties of different chemicals may be due to different individual triggering mechanisms involved in the transformation process.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.